IMC Chicago
IONS icon

IMC Chicago’s Ionis Pharmaceuticals IONS Stock Holding History

IMC Chicago’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.12M Buy
+25,075
New +$1.42M ﹤0.01% 3773

Other funds holding IONS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Tweedy, Browne Co
Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return

IMC Chicago's IONS Position: Q3 2026 in Review

IMC Chicago opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 25,075 shares worth $1.12M. The stake represents ﹤0.01% of the portfolio and ranks #3773 among its holdings.

194 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • IMC Chicago held 25,075 shares of Ionis Pharmaceuticals worth $1.12M as of Q3 2026.
  • Ionis Pharmaceuticals was a new IMC Chicago position in Q3 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #3773 holding.
  • 194 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.